Merck Insomnia Drug Safe Only in Low Doses

May 23 (Bloomberg) -- Merck & Co.’s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi’s Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
The Algorithm Taking On Rap's Finest
39:57 - Big-data researchers in Finland created an algorithm they say composes rap lyrics with 21 percent more rhymes than any human rapper. Bloomberg West put the program to the test against Chicago speed-style rapper Twista. (Source: Bloomberg)
  • Intel's James Steps Down to Seek CEO Role Elsewhere
  • What Does Jobs Report Mean for the FED?
  • Popeyes CEO: The Sky Is the Limit for Our Brand Globally